These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3318183)

  • 1. [Cholecystokinin-peptides--new knowledge and possibilities for clinical use].
    Nieber K; Henklein P; Ott T; Oehme P
    Z Gesamte Inn Med; 1987 Sep; 42(18):501-6. PubMed ID: 3318183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of cholecystokinin in appetite control and body weight regulation.
    Little TJ; Horowitz M; Feinle-Bisset C
    Obes Rev; 2005 Nov; 6(4):297-306. PubMed ID: 16246215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurobiology of cholecystokinin.
    Moran TH; Schwartz GJ
    Crit Rev Neurobiol; 1994; 9(1):1-28. PubMed ID: 8828002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptidergic control of food intake in food-producing animals.
    Baile CA; Della-Fera MA
    Fed Proc; 1984 Nov; 43(14):2898-902. PubMed ID: 6092147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholecystokinin and endogenous opioid peptides: interactive influence on pain, cognition, and emotion.
    Hebb AL; Poulin JF; Roach SP; Zacharko RM; Drolet G
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Dec; 29(8):1225-38. PubMed ID: 16242828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical endocrinology and metabolism. Cholecystokinin.
    Rehfeld JF
    Best Pract Res Clin Endocrinol Metab; 2004 Dec; 18(4):569-86. PubMed ID: 15533776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovine model for clear-cut study on the role of cholecystokinin in antral, small intestinal and gallbladder motility.
    Romański KW
    Pol J Pharmacol; 2004; 56(2):247-56. PubMed ID: 15156076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fat in the intestine as a regulator of appetite--role of CCK.
    Beglinger C; Degen L
    Physiol Behav; 2004 Dec; 83(4):617-21. PubMed ID: 15621067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut peptides and postprandial satiety.
    Smith GP; Gibbs J
    Fed Proc; 1984 Nov; 43(14):2889-92. PubMed ID: 6149153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
    Béhé M; Behr TM
    Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin antagonists: pharmacological and therapeutic potential.
    Herranz R
    Med Res Rev; 2003 Sep; 23(5):559-605. PubMed ID: 12789687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasodilatory effects of cholecystokinin: new role for an old peptide?
    Ruiz-Gayo M; González MC; Fernández-Alfonso S
    Regul Pept; 2006 Dec; 137(3):179-84. PubMed ID: 16889840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances in gastrointestinal hormones: cholecystokinin].
    Ubilluz R
    Rev Gastroenterol Peru; 1994; 14(3):222-32. PubMed ID: 8000026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential.
    Behr TM; Béhé M; Angerstein C; Gratz S; Mach R; Hagemann L; Jenner N; Stiehler M; Frank-Raue K; Raue F; Becker W
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3124s-3138s. PubMed ID: 10541353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholecystokinin: proofs and prospects for involvement in control of food intake and body weight.
    Ritter RC; Covasa M; Matson CA
    Neuropeptides; 1999 Oct; 33(5):387-99. PubMed ID: 10657516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Receptors for cholecystokinin and gastrin].
    de Weerth A; Bläker M; von Schrenck T
    Z Gastroenterol; 1999 May; 37(5):389-401. PubMed ID: 10413847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptides of the cholecystokinin group: effects and mechanisms of action on the gastro-intestinal and gall bladder motility.
    Milenov K; Kalfin R; Todorov S; Raichev P
    Acta Physiol Pharmacol Bulg; 1998; 23(3-4):85-91. PubMed ID: 10672334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholecystokinin and panic disorder: past and future clinical research strategies.
    Bradwejn J; Koszycki D
    Scand J Clin Lab Invest Suppl; 2001; 234():19-27. PubMed ID: 11713976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of vagal afferent excitation and reduction of food intake by leptin and cholecystokinin.
    Peters JH; Simasko SM; Ritter RC
    Physiol Behav; 2006 Nov; 89(4):477-85. PubMed ID: 16872644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ontogeny of postingestive inhibitory stimuli: examining the role of CCK.
    Weller A
    Dev Psychobiol; 2006 Jul; 48(5):368-79. PubMed ID: 16770766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.